Akso Health Group (AHG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AHG SEC filings page.
Akso Health Group (AHG) reported $13.8M in revenue for fiscal year 2026, down 6.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business operates with thin-to-negative gross economics and equity-heavy financing, while reported losses translate into uneven cash generation.
FY2025 paired a reported net loss with positive operating cash flow of$1.2M ; FY2026 instead produced operating cash flow of-$12.8M . With revenue close to$14M in both years, cash generation is not tracking reported earnings or sales scale, indicating materially different non-operating and working-capital effects across periods.
The balance sheet is asset-heavy relative to operating scale: FY2026 total assets were
Gross margin moved from
Financial Health Signals
Akso Health Group does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Akso Health Group scores 80.39, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.2B) relative to total liabilities ($8.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Akso Health Group passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.
Akso Health Group reported a net loss of $18.7M while operations used $12.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2026.
Cash & Balance Sheet
Akso Health Group held $171K in cash as of Q4 2026; long-term debt is not reported for that period.
Not reported for Q4 2026.
Not reported for Q4 2026.
Margins & Returns
None of these metrics is reported for Q4 2026.
Capital Allocation
None of these metrics is reported for Q4 2026.
AHG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
AHG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2620-F | Q2'266-K | Q4'2520-F | Q2'2510-Q | Q4'2420-F | Q2'2410-Q | Q4'2310-K | Q2'2310-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $189.6M-11.8% | $212.0M-0.4% | $215.0M+51.4% | $212.9M+1161.5% | $142.0M+594.1% | $16.9M-19.3% | $20.5M-67.4% | $20.9M |
| Current Assets | $189.5M-3.4% | $18.4M-81.7% | $196.1M+38.1% | $100.2M+493.7% | $142.0M+594.1% | $16.9M-19.1% | $20.5M-67.4% | $20.9M |
| Cash & Equivalents | $171K-99.9% | $11.1M-87.8% | $176.2M+106.9% | $91.4M+891.9% | $85.2M+974.8% | $9.2M-7.8% | $7.9M-57.0% | $10.0M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $200K+5.2% | $194K-1.4% | $190K-0.5% | $197K-84.0% | $191K-88.7% | $1.2M+36.4% | $1.7M-78.4% | $900K |
| Accounts Receivable | $1.3M+34.3% | $3.2M+676.4% | $954K | $408K-93.0% | N/A | $5.8M | $7.7M | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | N/A | $11.0M-90.2% | $10.8M-79.2% | $112.5M | $52.1M | N/A | N/A | N/A |
| Total Liabilities | $8.7M-44.9% | $13.7M+11.7% | $15.8M+339.7% | $12.3M+6.5% | $3.6M-69.1% | $11.5M+5.2% | $11.6M-77.0% | $11.0M |
| Current Liabilities | $8.7M-37.0% | $12.0M-1.8% | $13.8M+284.3% | $12.2M+5.9% | $3.6M-69.1% | $11.5M+5.2% | $11.6M-77.0% | $11.0M |
| Non-Current Liabilities | $3K-99.9% | $1.7M+2582.9% | $2.0M | $64K | $0 | $0 | $0 | $0 |
| Total Equity | $180.9M-9.1% | $198.3M-1.1% | $199.1M+43.9% | $200.6M+3739.7% | $138.4M+1485.8% | $5.2M-47.3% | $8.7M-29.0% | $9.9M |
| Retained Earnings | -$217.6M-9.4% | -$200.2M-210.3% | -$198.9M-211.1% | -$64.5M-11.4% | -$63.9M-17.4% | -$57.9M-10.8% | -$54.5M-2.6% | -$52.3M |
Not reported in any period shown, so not listed: Long-Term Debt.
AHG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
AHG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Akso Health Group AHG | FY2026 | $13.8M | -$18.7M | N/A | $1.2B | — |
| Owens & Minor, Inc. OMI | FY2025 | $2.8B | -$1.1B | -39.9% | $216.6M | 22/100 |
| Henry Schein Inc HSIC | FY2025 | $13.2B | $419.0M | 3.2% | $9.4B | 46/100 |
| Quipt Home Medical Corp. QIPT | FY2025 | $245.4M | -$10.7M | -4.4% | $162.3M | 38/100 |
| 111, Inc. YI | FY2025 | $1.8B | -$3.2M | -0.2% | $27.4M | 19/100 |
| InMode Ltd. INMD | FY2025 | $370.5M | $93.8M | 25.3% | $822.9M | 74/100 |
Where Akso Health Group Ranks
Frequently Asked Questions
What is Akso Health Group's annual revenue?
Akso Health Group (AHG) reported $13.8M in total revenue for fiscal year 2026. This represents a -6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Akso Health Group's revenue growing?
Akso Health Group (AHG) revenue declined by 6.4% year-over-year, from $14.8M to $13.8M in fiscal year 2026.
Is Akso Health Group profitable?
No, Akso Health Group (AHG) reported a net income of -$18.7M in fiscal year 2026.
What is Akso Health Group's EBITDA?
Akso Health Group (AHG) had EBITDA of -$18.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Akso Health Group's gross margin?
Akso Health Group (AHG) had a gross margin of -0.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Akso Health Group's return on equity (ROE)?
Akso Health Group (AHG) has a return on equity of -10.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Akso Health Group's free cash flow?
Akso Health Group (AHG) recorded an outflow of $12.8M in free cash flow during fiscal year 2026. This represents a -1350.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Akso Health Group's operating cash flow?
Akso Health Group (AHG) recorded an outflow of $12.8M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
What are Akso Health Group's total assets?
Akso Health Group (AHG) had $189.6M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Akso Health Group's capital expenditures?
Akso Health Group (AHG) invested $2K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Akso Health Group's current ratio?
Akso Health Group (AHG) had a current ratio of 21.77 as of fiscal year 2026, which is generally considered healthy.
What is Akso Health Group's debt-to-equity ratio?
Akso Health Group (AHG) had a debt-to-equity ratio of 0.05 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Akso Health Group's return on assets (ROA)?
Akso Health Group (AHG) had a return on assets of -9.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Akso Health Group's P/E ratio?
Akso Health Group (AHG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $1.2B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Akso Health Group's price-to-sales ratio?
Akso Health Group (AHG) trades at 85.2x sales, its market capitalization divided by revenue of $13.8M revenue, FY2026. The market capitalization is $1.2B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Akso Health Group's liquidity compare with its operating cash outflow?
At the end of fiscal year 2026, Akso Health Group (AHG) held $171K in cash, cash equivalents and investments, and reported an operating cash outflow of $12.8M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Akso Health Group's Altman Z-Score?
Akso Health Group (AHG) has an Altman Z-Score of 80.39, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Akso Health Group's Piotroski F-Score?
Akso Health Group (AHG) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Akso Health Group's earnings high quality?
Akso Health Group (AHG) reported a net loss of $18.7M while operations used $12.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.